12:00 AM
Mar 23, 2009
 |  BC Week In Review  |  Company News  |  Other News

Penwest drug delivery, neurology news

Shareholders Tang Capital Partners L.P. and Perceptive Life Sciences Master Fund Ltd. demanded to inspect Penwest's books and records after the biotech declined to adopt their recommendation to wind down operations and elect three directors chosen by Tang and Perceptive. Tang and Perceptive, which together own a 42% stake in Penwest,...

Read the full 235 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >